Gemcitabine is commonly used for various solid organ malignancies with rarely reported cardiac side effects such as cardiomyopathy. Pazopanib usually can cause arterial hypertension but cases of heart failure have recently been re-ported. We describe a case of fatal heart failure after treatment with gemcitabine and pazopanib in a 55-year-old female with sarcoma. Patient developed left ventricular dysfunction after gemcitabine treatment and acute heart failure after 22 days of pazopanib treatment which led to death. Physicians should be aware of the cardiotoxicity risk when managing the use of pazopanib especially in patients previously treated with other cardiotoxic drugs.

Di Lisi D., Manno G., Filorizzo C., Guarino T., Santanelli G., Lunetta M., et al. (2020). Fatal heart failure induced by pazopanib in a sarcoma patient previously treated with gemcitabine. JOURNAL OF THE SAUDI HEART ASSOCIATION, 32(2), 285-287 [10.37616/2212-5043.1125].

Fatal heart failure induced by pazopanib in a sarcoma patient previously treated with gemcitabine

Di Lisi D.;Manno G.
;
Filorizzo C.;Guarino T.;Santanelli G.;Lunetta M.;Badalamenti G.;Russo A.;Novo G.
2020

Abstract

Gemcitabine is commonly used for various solid organ malignancies with rarely reported cardiac side effects such as cardiomyopathy. Pazopanib usually can cause arterial hypertension but cases of heart failure have recently been re-ported. We describe a case of fatal heart failure after treatment with gemcitabine and pazopanib in a 55-year-old female with sarcoma. Patient developed left ventricular dysfunction after gemcitabine treatment and acute heart failure after 22 days of pazopanib treatment which led to death. Physicians should be aware of the cardiotoxicity risk when managing the use of pazopanib especially in patients previously treated with other cardiotoxic drugs.
Di Lisi D., Manno G., Filorizzo C., Guarino T., Santanelli G., Lunetta M., et al. (2020). Fatal heart failure induced by pazopanib in a sarcoma patient previously treated with gemcitabine. JOURNAL OF THE SAUDI HEART ASSOCIATION, 32(2), 285-287 [10.37616/2212-5043.1125].
File in questo prodotto:
File Dimensione Formato  
Fatal heart failure induced by pazopanib..pdf

accesso aperto

Dimensione 128.99 kB
Formato Adobe PDF
128.99 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/439072
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact